Saladax Biomedical, Inc.

SALADAX BIOMEDICAL, INC. Saladax produces MyCare™, sophisticated blood tests that quickly, accurately, and inexpensively determine systemic chemotherapy drug levels that enable oncologists to personalize dosing for optimal results in cancer patients. Saladax, one of two anchor companies at Ben Franklin TechVentures, has raised more than $40 million in follow-on funding and has forged an important strategic alliance with the large Chinese company, Fosun Pharmaceuticals.